Eledon Pharmaceuticals, Inc. (ELDN) Tops Q3 EPS by 8c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q3 EPS of ($0.35), $0.08 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Is Treasury selloff a major issue for stock market bulls?